Early Detection Research Network

Brassil, Diane N.

Contact Information

Email: mailto:brassidn@evms.edu
Fax: (757) 446-5766
1282
None given

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

None Available.

Closed Protocols

No closed protocols.

Publications

Publication Name PubMed ID Journal
A novel approach for clustering proteomics data using Bayesian fast Fourier transform. 15769836 Bioinformatics
A novel approach toward development of a rapid blood test for breast cancer. 14499014 Clin. Breast Cancer
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. 17981926 Clin. Chem.
Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer. 16552720 J. Cell. Biochem.
Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. 12324514 Clin. Chem.
Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate. 29330297 Mol. Cancer Res.
Clinical proteomics: A need to define the field and to begin to set adequate standards. 21136664 Proteomics Clin Appl
Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. 14997503 Proteomics
Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality data. 12762451 Biometrics
Deconvolution filters to enhance resolution of dense time-of-flight survey spectra in the time-lag optimization range. 16636999 Rapid Commun. Mass Spectrom.
Defining the role of mass spectrometry in cancer diagnostics. 15466969 Cancer Epidemiol. Biomarkers Prev.
Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. 11290567 Am. J. Pathol.
Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. 18043497 Laryngoscope
Endothelial-to-Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction. 31434495 Arterioscler. Thromb. Vasc. Biol.
Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques. 15550476 Clin. Chem.
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. 15613711 Clin. Chem.
Expression of genes and proteins specific for prostate cancer. 15535438 J. Urol.
Feature extraction in the analysis of proteomic mass spectra. 16502467 Proteomics
Functional clustering algorithm for high-dimensional proteomics data. 16046812 J. Biomed. Biotechnol.
Generation of a baculovirus recombinant prostate-specific membrane antigen and its use in the development of a novel protein biochip quantitative immunoassay. 10833385 Protein Expr. Purif.
Identification of patients with head and neck cancer using serum protein profiles. 14732777 Arch. Otolaryngol. Head Neck Surg.
Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. 16760258 Mol. Cell Proteomics
Measurement reproducibility in the early stages of biomarker development. 15665389 Dis. Markers
Mining the low molecular weight proteome of blood. 21136732 Proteomics Clin Appl
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements. 18606634 Clin. Chem.
Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. 12171882 Clin. Cancer Res.
Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range. 17918874 J. Proteome Res.
Overexpression of alpha-defensin is associated with bladder cancer invasiveness. 16520271 Urol. Oncol.
Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. 15112261 Cancer
Protein profiling in urine for the diagnosis of bladder cancer. 15277356 Clin. Chem.
Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. 12497173 Prostate Cancer Prostatic Dis.
Proteomic approaches to biomarker discovery in prostate and bladder cancers. 11721637 Proteomics
Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. 11708463 Ann. N. Y. Acad. Sci.
Proteomic strategies for biomarker identification: progress and challenges. 11249741 Curr. Opin. Mol. Ther.
Proteomics in early detection of cancer. 11568117 Clin. Chem.
Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. 11507047 Cancer Res.
Resampling and deconvolution of linear time-of-flight records for enhanced protein profiling. 16637003 Rapid Commun. Mass Spectrom.
SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression. 17705230 Prostate
SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. 15726646 Hepatology
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. 18024530 Clin. Chem.
SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers. 15258337 Dis. Markers
Selective capture of prostatic basal cells and secretory epithelial cells for proteomic and genomic analysis. 15283892 Urol. Oncol.
Serum biomarkers to differentiate benign and malignant mammographic lesions. 17481542 J. Am. Coll. Surg.
Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. 15709174 Clin. Cancer Res.
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer. 15258333 Dis. Markers
Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. 12097261 Cancer Res.
Serum protein profiles to identify head and neck cancer. 15014013 Clin. Cancer Res.
Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers. 15723595 Expert Rev. Mol. Diagn.
Signal detection in high-resolution mass spectrometry data. 18173224 J. Proteome Res.
Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. 15383419 Ann. Surg. Oncol.
The "omics" haystack: defining sources of sample bias in expression profiling. 16120944 Clin. Chem.
The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology. 15283893 Urol. Oncol.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Version 5.0.2